4//SEC Filing
Tada Hiroomi 4
Accession 0001209191-21-063019
CIK 0001863127other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 7:52 PM ET
Size
9.8 KB
Accession
0001209191-21-063019
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-02+7,964→ 7,964 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (7,964 underlying) - Award
Stock Option (Right to Buy)
2021-11-02+83,626→ 83,626 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (83,626 underlying) - Award
Stock Option (Right to Buy)
2021-11-02+7,964→ 7,964 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (7,964 underlying)
Footnotes (2)
- [F1]1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F2]The option vests based on achievement of a performance objective.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880593
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 7:52 PM ET
- Size
- 9.8 KB